1-(吡咯烷-1-基)戊-4-炔-1-酮 | 13991-18-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 1-(吡咯烷-1-基)戊-4-炔-1-酮
• 英文名称: 1-(pyrrolidin-1-yl)pent-4-yn-1-one
• 英文别名: 1-Pyrrolidin-1-ylpent-4-yn-1-one
• CAS: 13991-18-9
• 化学式: C₉H₁₃NO
• 分子量: 151.208
• InChiKey: CQIAJFMHBHPKOU-UHFFFAOYSA-N

物化性质

• 沸点：
  145-146 °C
• 密度：
  1.047±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(吡咯烷-1-基)戊-4-炔-1-酮 在 四氯化钛 、 potassium carbonate 、 四乙基对甲苯磺酸铵 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 33.5h， 生成 1-aza-5-chloro-2-oxo-5-bicyclo<5.3.0>dec-5-ene
  参考文献：
  名称：

  阳极酰胺氧化：关于六元环和七元环在胺上环化的基础研究

  摘要：

  已经研究了烯烃和炔属亲核试剂与用于将六元和七元环融合到胺上的基于电化学的环化程序的相容性。发现单取代的烯烃和乙炔都是将七元环环合到胺上的良好亲核试剂。二取代的烯烃和乙炔似乎是完成六元环在胺上环化的良好亲核试剂。此外，还研究了几种脯氨酸衍生物与环合程序的相容性。

  DOI：

  10.1016/s0040-4020(01)87048-4
• 作为产物：
  描述：

  四氢吡咯 、 1-(4-pentynoyl)imidazole 以 四氢呋喃 为溶剂， 反应 8.0h， 生成 1-(吡咯烷-1-基)戊-4-炔-1-酮
  参考文献：
  名称：

  A Tandem Cyclization-Onium Ylide Rearrangement-Cycloaddition Sequence for the Synthesis of Benzo-Substituted Cyclopentenones

  摘要：

  A new annulation sequence leading to benzo-substituted cyclopentenones is effected by treating o-alkynyl-substituted alpha-diazoacetophenones containing tethered heteroatoms with Rh(II) carboxylates. The reaction involves addition of the initially formed keto carbenoid onto the acetylenic pi-bond to give a rearranged vinyl carbenoid. Sulfonium ylide formation occurred both intra- and intermolecularly when the reaction was carried out in the presence of a sulfide. In the case where an ether oxygen was present on the backbone of the vinyl carbenoid, the resulting oxonium ylide underwent a [1,2]- or [2,3]-shift to give the rearranged product. These cyclic metallocarbenoids were also found to interact with a neighboring carbonyl or oximino pi-bond to produce carbonyl or azomethine ylides. The 1,3-dipoles generated in this manner were trapped with dimethyl acetylenedicarboxylate. The domino transformation was also performed intramolecularly by attaching a trapping agent directly to the carbonyl group. Incorporation of an amido carbonyl on the alkyne side chain was found to dramatically alter the course of the tandem annulation reaction. A novel rearranged cycloadduct was formed in high yield whose structure was elucidated by X-ray crystallography. The mechanism for its formation involves the opening of a transient intermediate oxabicyclo[2.2.1]heptane followed by a Wagner-Meerwein rearrangement.

  DOI：

  10.1021/jo00106a014

文献信息

• Catalytic Hydrogenation of Amides to Amines under Mild Conditions
  作者：Mario Stein、Bernhard Breit

  DOI：10.1002/anie.201207803

  日期：2013.2.18

  Under (not so much) pressure: A general method for the hydrogenation of tertiary and secondary amides to amines with excellent selectivity using a bimetallic Pd–Re catalyst has been developed. The reaction proceeds under low pressure and comparatively low temperature. This method provides organic chemists with a simple and reliable tool for the synthesis of amines.

  在（不是很大）压力下：已开发出一种使用双金属Pd-Re催化剂将叔酰胺和仲酰胺氢化成胺的通用方法，具有优异的选择性。反应在低压和较低温度下进行。该方法为有机化学家提供了一种简单可靠的胺合成工具。
• [EN] TRICYCLIC PYRAZOLE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASES A BASE DE TYRAZOLES TRICYCLIQUES
  申请人：ABBOTT LAB

  公开号：WO2005095387A1

  公开（公告）日：2005-10-13

  Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  本发明的化合物对抑制蛋白酪氨酸激酶具有用处。还公开了制备这些化合物的方法、含有这些化合物的组合物以及使用这些化合物进行治疗的方法。
• HETEROCYCLIC COMPOUNDS AND USES THEREOF
  申请人：CASTRO Alfredo C.

  公开号：US20130053362A1

  公开（公告）日：2013-02-28

  Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein.

  本文描述了调节激酶活性的化合物和药物组合物，包括PI3激酶活性，以及与激酶活性相关的疾病和病况的治疗方法，包括PI3激酶活性的化合物、药物组合物和治疗方法。
• Tricyclic pyrazole kinase inhibitors
  申请人：Arnold D. Lee

  公开号：US20060014816A1

  公开（公告）日：2006-01-19

  Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  本发明的化合物可用于抑制蛋白酪氨酸激酶。还公开了制备该化合物的方法，含有该化合物的组合物，以及使用该化合物的治疗方法。
• Heterocyclic compounds and uses thereof
  申请人：Castro Alfredo C.

  公开号：US08785470B2

  公开（公告）日：2014-07-22

  Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

  本文描述了调节激酶活性（包括PI3激酶活性）的化合物和制药组合物，以及与激酶活性（包括PI3激酶活性）相关的疾病和病症的治疗方法、化合物和制药组合物。